EirGenix Inc. (TPE:6589)
Taiwan · Delayed Price · Currency is TWD 50.70
+1.00 (2.01%)
Aug 26, 2026, 1:19 PM CST
EirGenix Market Cap
EirGenix has a market cap or net worth of 15.05 billion as of August 25, 2026. Its market cap has decreased by -19.18% in one year.
Market Cap
15.05B
Enterprise Value
13.90B
Revenue
1.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
50.70
ChartMarket Cap Chart
Since November 23, 2016, EirGenix's market cap has increased from 4.56B to 15.05B, an increase of 230.29%. That is a compound annual growth rate of 13.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 15.05B | -19.37% |
| Dec 31, 2025 | 18.67B | -15.33% |
| Dec 31, 2024 | 22.05B | -28.29% |
| Dec 29, 2023 | 30.75B | -17.85% |
| Dec 30, 2022 | 37.43B | 11.81% |
| Dec 30, 2021 | 33.48B | 245.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 22.51B |
| Sunmax Biotechnology | 21.73B |
| Medigen Vaccine Biologics | 18.51B |
| TaiMed Biologics | 17.43B |
| Ever Supreme Bio Technology | 15.88B |
| Gongwin Biopharm Holdings | 14.00B |
| Lumosa Therapeutics | 12.98B |
| ACRO Biomedical | 12.93B |